Full-length hepatitis B virus sequences from naïve patients with fluctuation of viral load during ADV monotherapy

Yongwei Li1, Mingfen Zhu, Yunwei Guo

  • 1Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Virus Genes
|December 17, 2009
PubMed

Insights

Adefovir dipivoxil (ADV) treatment failures in hepatitis B virus (HBV) patients were linked to frequent viral mutations, not previously identified ADV-resistant ones. These genetic changes may impact treatment effectiveness and disease progression.

Area of Science:

  • Hepatology
  • Virology
  • Genetics

Background:

  • Adefovir dipivoxil (ADV) is used to treat chronic hepatitis B virus (HBV) infection.
  • Treatment failures with ADV can occur, but the underlying viral genetic factors are not fully understood.
  • Previous studies have limited data on full-length HBV genomes from patients experiencing ADV treatment failure.

Purpose of the Study:

  • To investigate the full-length hepatitis B virus (HBV) genome in patients experiencing adefovir dipivoxil (ADV) treatment failure.
  • To identify viral mutations associated with ADV treatment failure.
  • To explore the potential impact of these mutations on antiviral efficacy.

Main Methods:

  • Sequencing of 16 full-length HBV genomes from four patients who experienced treatment failure during a phase III clinical trial.
  • Analysis of viral substitutions at multiple time points (weeks 28, 52, and 92).
  • Correlation analysis between HBV-DNA levels, viral substitution frequency, and treatment outcomes.

Main Results:

  • No known adefovir dipivoxil-resistant mutations were detected in the studied patients.
  • A higher frequency of viral substitutions was observed at week 52, correlating negatively with HBV-DNA reduction.
  • Mutations in immunogenic epitopes and conserved polymerase gene sites, along with deletions in the X gene and basal core promoter/pre-core mutations, were noted during ADV treatment.

Conclusions:

  • Viral genetic changes, including mutations in epitopes and conserved regions, may contribute to adefovir dipivoxil treatment failure, independent of known resistance mutations.
  • Further research is needed to understand how these specific substitutions influence HBV replication, disease progression, and treatment response.
  • The development of more potent antiviral agents may be crucial for managing ADV treatment failures and ensuring public health.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...